Post-COVID-19 acute sarcopenia: physiopathology and management

K Piotrowicz, J Gąsowski, JP Michel… - Aging clinical and …, 2021 - Springer
In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review

I Cheruiyot, V Kipkorir, B Ngure, M Misiani… - Annals of vascular …, 2021 - Elsevier
Background Emerging evidence suggests that severe form of coronavirus disease 2019
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …

The psychological impact of the COVID-19 outbreak on health professionals: a cross-sectional study

EM Giusti, E Pedroli, GE D'Aniello… - Frontiers in …, 2020 - frontiersin.org
Background: The COVID-19 pandemic had a massive impact on health care systems,
increasing the risks of psychological distress in health professionals. This study aims at …

Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: A systematic analysis

RJD Sorensen, RM Barber, DM Pigott, A Carter… - The Lancet, 2022 - iris.uniroma1.it
Background The infection-fatality ratio (IFR) is a metric that quantifies the likelihood of an
individual dying once infected with a pathogen. Understanding the determinants of IFR …

COVID-19 and excess mortality in the United States: A county-level analysis

AC Stokes, DJ Lundberg, IT Elo, K Hempstead… - PLoS …, 2021 - journals.plos.org
Background Coronavirus Disease 2019 (COVID-19) excess deaths refer to increases in
mortality over what would normally have been expected in the absence of the COVID-19 …

[HTML][HTML] S1-Leitlinie post-COVID/long-COVID

AR Koczulla, T Ankermann, U Behrends, P Berlit… - …, 2021 - thieme-connect.com
Die Deutsche Gesellschaft für Pneumologie hat die AWMFS1-Leitlinie Post-COVID/Long-
COVID initiiert. In einem breiten interdisziplinären Ansatz wurde diese S1-Leitlinie …

The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies

N Zhao, B Di, L Xu - Cytokine & growth factor reviews, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations …

Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients

J Sui, DF Noubouossie, S Gandotra… - Frontiers in cellular and …, 2021 - frontiersin.org
Background The coronavirus disease-19 (COVID-19) is characterized with intense
inflammatory response, cardiac involvement, and coagulopathy. Fibrinogen, as a biomarker …

The inflammasome in times of COVID-19

JC de Rivero Vaccari, WD Dietrich, RW Keane… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses (CoVs) are members of the genus Betacoronavirus and the Coronaviridiae
family responsible for infections such as severe acute respiratory syndrome (SARS), Middle …

Angiotensin II type I receptor (AT1R): the gate towards COVID-19-associated diseases

G El-Arif, S Khazaal, A Farhat, J Harb, C Annweiler… - Molecules, 2022 - mdpi.com
The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike
glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its …